CLINICAL_TRIALS
trial_result
· 2014-11-11
Clinical Trial Update: Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder [Phase 3]
Summary
This document reports the completion and posting of results for a Phase 3 trial evaluating vortioxetine (Lu AA21004) for major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-11-11